Fox Run Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Fox Run Management's NVO Position: Q1 2026 in Review
Fox Run Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,118 shares — an estimated $210K sold.
Fox Run Management first reported a position in NVO in Q2 2016 and held it in 12 quarters. The position peaked at $1.05M in Q1 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Fox Run Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Fox Run Management sold 4,118 Novo Nordisk shares in Q1 2026, an estimated $210K.
- Fox Run Management first reported a position in Novo Nordisk in Q2 2016 and held it in 12 quarters.
- Fox Run Management's Novo Nordisk position peaked at $1.05M in Q1 2025.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.